Vorasidenib for Certain IDH-Mutant Gliomas: Is It Worth It? ...Middle East

Medscape - News
source : Medscape ( Middle East ) () 43
Experts debate the value of the new agent for low-grade gliomas with an IDH1 or IDH2 mutation. Some have hailed the drug a “breakthrough,” whereas others call the approval “premature.” Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Vorasidenib for Certain IDH-Mutant Gliomas: Is It Worth It? )

Also on site :

Most viewed in News
Blue Line service suspended after victim fatally struck by train
NBC Chicago - before 11 hour & 40 minute
Trump names Russia’s ‘big concession’ on Ukraine
Russia Today - before 6 hours & 56 minute
Justin Bieber Fans Enraged Over 'Disrespectful' Paparazzi Video
Parade - before 7 hours & 36 minute
Debbie Harry, 79, Makes First Red Carpet Appearance Since Bandmate's Death
Parade - before 11 hour & 18 minute
Pope Francis funeral latest: US cardinal accused of mishandling child sex abuse cases chosen to close casket
Independent - before 9 hours & 59 minute
Today's Wordle Hint, Answer for 1406 on Friday, April 25, 2025
Parade - before 9 hours & 43 minute
Russia is ‘ready for a deal’ with US on Ukraine – Lavrov
Russia Today - before 9 hours & 34 minute
Women Who Become Lonelier as They Get Older Usually Display These 6 Subtle Behaviors, Psychologists Say
Parade - before 3 hours & 32 minute
“Red Heel Heist” sparks one-of-a-kind News Channel 3 investigation in Isla Vista
News channel - before 11 hour & 42 minute
Yemen’s Houthi fighters down $200m worth of US drones in under six weeks
Aljazeera - before 6 hours & 15 minute
Fewer parties, less glam as DC readies for 'weird' Trump 2.0 Correspondents' dinner
The Hill - before 3 hours & 33 minute
Outrage as mourners take selfies with Pope Francis’ open casket
Independent - before 8 hours & 57 minute


Latest News

AUDUSD consolidated highs this week and under key resistance. What next technically?

before 2 minute

German ambassador ‘really optimistic’ about new post-Brexit youth visa scheme despite confusion in UK government

before 3 minute

Eighties movie pin up unrecognizable 43 years after hit film with Goldie Hawn – do you know who she is?

before 3 minute

US to loosen rules on Tesla, other carmakers taking on China in race for self-driving cars

before 3 minute

Clinique’s new foundation is powered by vitamins — and packs serious sun protection

before 3 minute

Acne vaccine: Experimental shot for common skin condition reaches clinical trials. Here's what you need to know.

before 3 minute

Trial dates set for former mayor of Liverpool Joe Anderson and co-defendants

before 3 minute

Trump says Xi called him, lays out trade and other deal plans in TIME interview

before 3 minute

Neusoft Launches Three Product Portfolios for AI-Powered Intelligent Mobility at Auto Shanghai 2025

before 6 minute

Woman unfairly dismissed from Marks and Spencer because she was pregnant, tribunal rules

before 8 minute

'Shark Tank' Inventor Tests Whether People Will Pay More for 'Made in USA'

before 8 minute

Bolsonaro’s doctors say the health of Brazil former president has stabilized

before 10 minute

Direct train service from Brighton to Newcastle planned

before 10 minute

Funnel clouds spotted in Denver metro during Thursday's storms

before 13 minute

CSK vs SRH Impact Players List- IPL 2025, Match 43

before 13 minute